BBWIMEDIUM SIGNALFINANCIAL10-K

BBWI shows mixed financial performance with declining profitability despite improved cash generation and strengthened liquidity position.

The company maintained strong operational cash flow growth while experiencing compressed margins that reduced net income and operating income. The substantial cash position increase suggests disciplined capital allocation, though rising current liabilities warrant monitoring for working capital efficiency.

Comparing 2026-03-12 vs 2025-03-14View on EDGAR →
FINANCIAL ANALYSIS

BBWI's financial profile shows contrasting trends with operating cash flow growing robustly to $1.1B while net income declined to $649M and operating income fell to $1.1B, indicating margin compression despite solid cash generation. The balance sheet strengthened notably with cash and equivalents rising 41% to $953M, though current liabilities increased 29% to $1.6B. Overall, the company demonstrates strong liquidity and cash conversion capabilities amid profitability headwinds.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+41.4%
$674.0M$953.0M

Cash position surged 41.4% — strong cash generation or capital raise providing significant financial cushion.

Current Liabilities
Balance Sheet
+29.2%
$1.2B$1.6B

Current liabilities rose 29.2% — increased short-term obligations, watch current ratio.

Operating Cash Flow
Cash Flow
+24.4%
$886.0M$1.1B

Operating cash flow grew 24.4% — strong conversion of earnings to cash, healthy business fundamentals.

Net Income
P&L
-18.7%
$798.0M$649.0M

Net income declined 18.7% — review whether driven by operations, interest costs, or non-recurring items.

Accounts Receivable
Balance Sheet
-12.2%
$205.0M$180.0M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Operating Income
P&L
-11.1%
$1.3B$1.1B

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Current Assets
Balance Sheet
+10.8%
$1.8B$2.0B

Current assets grew 10.8% — improving short-term liquidity or inventory/receivables build.

LANGUAGE CHANGES
NEW — 2026-03-12
PRIOR — 2025-03-14
ADDED
General Bath Body Works is a global leader in personal care and home fragrance, driven by the belief that everybody deserves to feel good.
For over 35 years, the brand s beloved and iconic scents have been expertly crafted for exceptional performance and a luxury fragrance experience.
Formulated with thoughtfully chosen ingredients, Bath Body Works body care products are available in multiple forms including fine fragrance mist, body cream, lotion, eau de parfum, body wash, hand soap, sanitizer and more, and home to our famous 3-wick candles.
Consumers can shop Bath Body Works anytime and anywhere they choose, from welcoming, in-store experiences at 1,927 company-operated stores in the United States of America ( U.S ) and Canada, our e-commerce sites in the U.S.
and Canada, 573 international stores and 34 e-commerce sites in more than 45 other countries, as well as Amazon.
+7 more — sign up free →
REMOVED
General The company, which was founded in 1963 in Columbus, Ohio, has evolved over time from an apparel-based specialty retailer to a global leader in personal care and home fragrance making the world a brighter, happier place through the power of fragrance.
For more than 30 years, customers have looked to Bath Body Works for quality, on-trend products and the newest, freshest fragrances which has positioned us as a global leader in personal care and home fragrance.
We sell home fragrance, body care and soap and sanitizer products under the Bath Body Works , White Barn and other brand names.
We care about our customers and believe in giving them a reason to celebrate with fragrance every day.
We remain committed to improving our communities and fostering an environment that is focused on delivering exceptional fragrances and experiences to our customers.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →